EDGAR Filing Documents for 0001493152-23-002944

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001493152-23-002944

Filing Date

2023-01-30

Accepted

2023-01-30 16:42:31

Documents

Period of Report

2022-10-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-k.htm	10-K	2521089
2		ex4-4.htm	EX-4.4	63980
3		ex4-5.htm	EX-4.5	23843
4		ex10-33.htm	EX-10.33	64614
5		ex10-34.htm	EX-10.34	33603
6		ex10-35.htm	EX-10.35	128199
7		ex10-36.htm	EX-10.36	35439
8		ex10-37.htm	EX-10.37	22216
9		ex10-38.htm	EX-10.38	80113
10		ex21-1.htm	EX-21.1	5950
11		ex31-1.htm	EX-31.1	11492
12		ex31-2.htm	EX-31.2	12377
13		ex32-1.htm	EX-32.1	6465
14		ex32-2.htm	EX-32.2	6135
15		form10-k_001.jpg	GRAPHIC	6154
16		form10-k_002.jpg	GRAPHIC	7078
17		form10-k_003.jpg	GRAPHIC	7760
18		form10-k_005.jpg	GRAPHIC	7720
19		form10-k_006.jpg	GRAPHIC	5887
20		form10-k_007.jpg	GRAPHIC	7081
21		form10-k_008.jpg	GRAPHIC	9883
22		form10-k_009.jpg	GRAPHIC	7736
23		form10-k_010.jpg	GRAPHIC	126274
	Complete submission text file	0001493152-23-002944.txt		3273425

Mailing Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403

Business Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403 (720) 859-4120

Vitro Biopharma, Inc. (Filer) CIK: 0000793171 (see all company filings)